ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

NCI advisors approve new grants programs. NCI funds consortium of cohorts. Funding opportunities listed.

August 1, 2003

Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators

May 3, 1974